McDonald’s Beats Pfizer on Growth; Investors Watch Now
As mid-2026 trading picks up, McDonald’s demonstrates stronger growth and cash flow versus Pfizer, which relies on in...
Both vehicle types have fee trade-offs. This guide shows how expense ratios and additional costs stack up to help you pick the cheaper option.
28,162 articlesAs mid-2026 trading picks up, McDonald’s demonstrates stronger growth and cash flow versus Pfizer, which relies on in...
Meta Platforms unveils a multi-year AI infrastructure plan with Nvidia valued around $115 billion to $135 billion for...
Gold climbs to new highs in March 2026 as a 2x gold ETF accelerates gains. With real yields sliding, leveraged exposu...
When the market rattles, some stocks prove more durable than others. This guide highlights two steady performers and ...
Barclays lowers Carvana's price target to $93 after a 5-for-1 stock split, while reaffirming an overweight stance as ...
Joby Aviation posted record Q4 2025 revenue driven by the Blade acquisition, but the stock remains volatile as cash b...
Alphabet’s billion flex is more than just cash. It’s a strategic playbook that powers buybacks, AI investments, and l...
As AI accelerates, the question on many investors' minds is will Nvidia stock soar. This article breaks down the driv...
The hype around SpaceX often drowns out solid opportunities in AI-powered space companies. This guide shines a light ...
Looking for biotech growth with real upside? This piece breaks down two innovative biotech stocks that could deliver ...
The death of Iran’s supreme leader elevates Hormuz risk, sending oil prices higher and lifting major refiners and ene...
UBS boosts its price target on Xcel Energy to $89 while maintaining a Buy rating, saying the stock could year-end hig...